Protective efficacy of the pan-fungal vaccine NXT-2 against vulvovaginal candidiasis in a murine model.
- Published in:
- NPJ Vaccines, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41541-025-01171-4
- By:
- Publication type:
- Article
Works by Willems, Hubertine M. E.
Results: 5
1
2
Vulvovaginal Candidiasis: A Current Understanding and Burning Questions.
- Published in:
- Journal of Fungi, 2020, v. 6, n. 1, p. 1, doi. 10.3390/jof6010027
- By:
- Publication type:
- Article
3
A variant ECE1 allele contributes to reduced pathogenicity of Candida albicans during vulvovaginal candidiasis.
- Published in:
- PLoS Pathogens, 2021, v. 17, n. 9, p. 1, doi. 10.1371/journal.ppat.1009884
- By:
- Publication type:
- Article
4
Impact of Intravenous Fat Emulsion Choice on Candida Biofilm, Hyphal Growth, and Catheter-Related Bloodstream Infections in Pediatric Patients.
- Published in:
- Journal of Infectious Diseases, 2024, v. 229, n. 2, p. 588, doi. 10.1093/infdis/jiad527
- By:
- Publication type:
- Article
5
The Interleukin (IL) 17R/IL-22R Signaling Axis Is Dispensable for Vulvovaginal Candidiasis Regardless of Estrogen Status.
- Published in:
- Journal of Infectious Diseases, 2020, v. 221, n. 9, p. 1554, doi. 10.1093/infdis/jiz649
- By:
- Publication type:
- Article